Mycophenolate Mofetil (MMF) and Residual Kidney Function in PD

A small randomized controlled trial of people on PD (N=60) looked at whether the immune-suppressing drug mycophenolate mofetil could help protect residual kidney function. After a year, those who received MMF had significantly higher urine volume and urine Kt/V than controls, with no serious complications.

Read the abstract » | (added 12-14-2017)